Please login to read the full article.
Scrip Regulatory Affairs
US FDA-industry study warns of RFID interference risks for implantables
13 January 2010
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Australian Senate panel inquiry expresses shock at patient experiences with DePuy hip devices; calls for stricter regulations
- US govt panel wants FDA to consider cybersecurity in pre- and post-market device reviews
- US bill seeks to improve use of accelerated approval pathway for ultra-rare drugs
- New French fee payment system puts industry at arm's length
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Other Informa Comments
